• Pacira Pharmaceuticals, Inc. announces pricing of its Initial Public Offering

    3 February 2011
    Download

  • Valeant Pharmaceuticals to acquire PharmaSwis S.A.

    1 February 2011
    Download

  • Successful sale of HBM portfolio company PharmaSwiss to Valeant

    1 February 2011
    Download

  • HBM BioVentures realises a profit of EUR 41.9 million through the sale of PharmaSwiss to Valeant

    1 February 2011
    Download

  • MiCardia Corp.: Optimizing mitral valve repair

    31 January 2011
    Download

  • Nabriva reports positive results from phase II trial of Pleuromutilin antibiotic BC-3781 in ABSSSI

    18 January 2011
    Download

  • PTC Therapeutics completes enrollment of Phase 3 trial in Cystic Fibrosis

    21 December 2010
    Download

  • Vivacta closes £4 million financing

    10 November 2010
    Download

  • mtm laboratories extends series C financing round by EUR 7 million (USD 9.7 million)

    8 November 2010
    Download

  • MiCardia corporation receives CE mark clearance to market enCor dynamic mitral valve repair system in te European Union

    3 November 2010
    Download

  • Abbott and Enanta present positive initial results from phase 2 study in Hepatitis C

    1 November 2010
    Download

  • Pivotal data suggest PTC Therapeutics' Ataluren slows loss of walking ability in muscular distrophy patients

    15 October 2010
    Download

  • Interventional Spine Inc. announces issuance of key patents for the PERPOS PLS System

    8 October 2010
    Download

  • Interventional Spine, Inc. awarded the 2010 Best New Technology In Cervical Care Award

    8 October 2010
    Download

  • HBM BioVentures sells its investment in Sloning

    7 October 2010
    Download

  • Lux Biosciences reports phase 1 safety results and open label efficacy results for LX214, a potential best-in-class treament for Dry Eye

    23 September 2010
    Download

  • Successful sale of Asthmatx, a company from HBM BioVentures' portfolio, to Boston Scientific increases liquidity by CHF 4 million

    21 September 2010
    Download

  • Nabriva Therapeutic's Pleuromutilin Antibiotic BC-3781 shows therapeutic potential for skin and lung infections with both oral and IV dosing in non-clinical and clinical Phase I studies

    10 September 2010
    Download

  • Vivacta re-aligns management in preparation for £4 million finanacing round

    26 August 2010
    Download

  • Devax receives CE Mark for the AXXESS drug eluting bifurcation stent

    29 July 2010
    Download

  • HBM BioVentures largest public investment - Micrus - acquired by Johnson & Johnson

    13 July 2010
    Download

  • Lux Biosciences names Dean Mitchell President and CEO

    1 July 2010
    Download

  • HBM Partners to launch new M&A Report at BioBusiness Network conference (29-30 September 2010, Geneva)

    30 June 2010
    Download

  • Anthera enrolls first patients in pivotal Varespladib phase 3 clinical study

    23 June 2010
    Download

  • PTC Therapeutics awarded $5.4 million grant from the Wellcome Trust

    7 June 2010
    Download
    • More news